{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:48:51Z","timestamp":1760784531819,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T00:00:00Z","timestamp":1536105600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12957-018-1482-7","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T10:28:57Z","timestamp":1536143337000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver-transplanted patient: a case report"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6264-9436","authenticated-orcid":false,"given":"Ebbe Billmann","family":"Thorgersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Espen","family":"Melum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trine","family":"Folseraas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stein Gunnar","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e5l Dag","family":"Line","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,5]]},"reference":[{"issue":"9904","key":"1482_CR1","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","volume":"382","author":"GM Hirschfield","year":"2013","unstructured":"Hirschfield GM, Karlsen TH, Lindor KD, Adams DH. Primary sclerosing cholangitis. Lancet. 2013;382(9904):1587\u201399.","journal-title":"Lancet"},{"issue":"1","key":"1482_CR2","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jhep.2013.09.020","volume":"60","author":"M Carbone","year":"2014","unstructured":"Carbone M, Neuberger JM. Autoimmune liver disease, autoimmunity and liver transplantation. J Hepatol. 2014;60(1):210\u201323.","journal-title":"J Hepatol"},{"issue":"9","key":"1482_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000000548","volume":"1","author":"IM Andersen","year":"2015","unstructured":"Andersen IM, Fosby B, Boberg KM, Clausen OP, Jebsen P, Melum E, et al. Indications and outcomes in liver transplantation in patients with primary sclerosing cholangitis in Norway. Transplant Direct. 2015;1(9):e39.","journal-title":"Transplant Direct"},{"issue":"1","key":"1482_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cld.2015.08.014","volume":"20","author":"T Folseraas","year":"2016","unstructured":"Folseraas T, Boberg KM. Cancer risk and surveillance in primary sclerosing cholangitis. Clin Liver Dis. 2016;20(1):79\u201398.","journal-title":"Clin Liver Dis"},{"issue":"1","key":"1482_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","volume":"40","author":"NJ Carr","year":"2016","unstructured":"Carr NJ, Cecil TD, Mohamed F, Sobin LH, Sugarbaker PH, Gonzalez-Moreno S, et al. A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the peritoneal surface oncology group international (PSOGI) modified Delphi process. Am J Surg Pathol. 2016;40(1):14\u201326.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"1482_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/00000658-199402000-00001","volume":"219","author":"PH Sugarbaker","year":"1994","unstructured":"Sugarbaker PH. Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon. Ann Surg. 1994;219(2):109\u201311.","journal-title":"Ann Surg"},{"issue":"2","key":"1482_CR7","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ejso.2007.04.002","volume":"34","author":"RM Smeenk","year":"2008","unstructured":"Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol. 2008;34(2):196\u2013201.","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"1482_CR8","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1097\/DCR.0b013e3182a62b0d","volume":"56","author":"S Dayal","year":"2013","unstructured":"Dayal S, Taflampas P, Riss S, Chandrakumaran K, Cecil TD, Mohamed F, et al. Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achieved. Dis Colon Rectum. 2013;56(12):1366\u201372.","journal-title":"Dis Colon Rectum"},{"issue":"10","key":"1482_CR9","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1046\/j.1365-2168.2000.01553.x","volume":"87","author":"J Esquivel","year":"2000","unstructured":"Esquivel J, Sugarbaker PH. Clinical presentation of the pseudomyxoma peritonei syndrome. Br J Surg. 2000;87(10):1414\u20138.","journal-title":"Br J Surg"},{"issue":"7","key":"1482_CR10","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1053\/crad.2002.0942","volume":"57","author":"TV Sulkin","year":"2002","unstructured":"Sulkin TV, O'Neill H, Amin AI, Moran B. CT in pseudomyxoma peritonei: a review of 17 cases. Clin Radiol. 2002;57(7):608\u201313.","journal-title":"Clin Radiol"},{"issue":"5","key":"1482_CR11","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ejso.2013.12.021","volume":"40","author":"P Taflampas","year":"2014","unstructured":"Taflampas P, Dayal S, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ. Pre-operative tumour marker status predicts recurrence and survival after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal pseudomyxoma peritonei: analysis of 519 patients. Eur J Surg Oncol. 2014;40(5):515\u201320.","journal-title":"Eur J Surg Oncol"},{"issue":"4 Suppl","key":"1482_CR12","first-page":"35","volume":"22","author":"M Deraco","year":"2003","unstructured":"Deraco M, De Simone M, Rossi CR, Cavaliere F, Di Filippo F, Vaira M, et al. An Italian multicentric phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with pseudomyxoma peritonei. J Exp Clin Cancer Res. 2003;22(4 Suppl):35\u20139.","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"1482_CR13","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1245\/s10434-009-0341-8","volume":"16","author":"TC Chua","year":"2009","unstructured":"Chua TC, Yan TD, Smigielski ME, Zhu KJ, Ng KM, Zhao J, et al. Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution. Ann Surg Oncol. 2009;16(7):1903\u201311.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"1482_CR14","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.ejso.2012.06.552","volume":"38","author":"O Sorensen","year":"2012","unstructured":"Sorensen O, Flatmark K, Reed W, Wiig JN, Dueland S, Giercksky KE, et al. Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in pseudomyxoma peritonei. Eur J Surg Oncol. 2012;38(10):969\u201376.","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"1482_CR15","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S1055-3207(03)00048-6","volume":"12","author":"PH Sugarbaker","year":"2003","unstructured":"Sugarbaker PH. Peritonectomy procedures. Surg Oncol Clin N Am. 2003;12(3):703\u201327. xiii","journal-title":"Surg Oncol Clin N Am"},{"issue":"4","key":"1482_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1055\/s-0035-1564431","volume":"28","author":"A Nadler","year":"2015","unstructured":"Nadler A, McCart JA, Govindarajan A. Peritoneal carcinomatosis from colon cancer: a systematic review of the data for cytoreduction and intraperitoneal chemotherapy. Clin Colon Rectal Surg. 2015;28(4):234\u201346.","journal-title":"Clin Colon Rectal Surg"},{"issue":"1","key":"1482_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejso.2005.09.016","volume":"32","author":"E de Bree","year":"2006","unstructured":"de Bree E, Koops W, Kroger R, van Ruth S, Verwaal VJ, Zoetmulder FA. Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol. 2006;32(1):65\u201371.","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"1482_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","volume":"28","author":"D Elias","year":"2010","unstructured":"Elias D, Gilly F, Boutitie F, Quenet F, Bereder JM, Mansvelt B, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2010;28(1):63\u20138.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1482_CR19","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/jso.24290","volume":"114","author":"IS Froysnes","year":"2016","unstructured":"Froysnes IS, Larsen SG, Spasojevic M, Dueland S, Flatmark K. Complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis in Norway: prognostic factors and oncologic outcome in a national patient cohort. J Surg Oncol. 2016;114(2):222\u20137.","journal-title":"J Surg Oncol"},{"issue":"3","key":"1482_CR20","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1245\/s10434-017-6315-3","volume":"25","author":"KI Votanopoulos","year":"2018","unstructured":"Votanopoulos KI, Bartlett D, Moran B, Haroon CM, Russell G, Pingpank JF, et al. PCI is not predictive of survival after complete CRS\/HIPEC in peritoneal dissemination from high-grade appendiceal primaries. Ann Surg Oncol. 2018;25(3):674\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"20","key":"1482_CR21","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","volume":"30","author":"TC Chua","year":"2012","unstructured":"Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30(20):2449\u201356.","journal-title":"J Clin Oncol"},{"key":"1482_CR22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359\u201374.","journal-title":"Cancer Treat Res"},{"issue":"2","key":"1482_CR23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/SLA.0b013e3181fc9d36","volume":"253","author":"W Khoury","year":"2011","unstructured":"Khoury W, Lavery IC, Kiran RP. Effects of chronic immunosuppression on long-term oncologic outcomes for colorectal cancer patients undergoing surgery. Ann Surg. 2011;253(2):323\u20137.","journal-title":"Ann Surg"},{"issue":"5","key":"1482_CR24","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/SLA.0b013e3182823957","volume":"257","author":"M Hagness","year":"2013","unstructured":"Hagness M, Foss A, Line PD, Scholz T, Jorgensen PF, Fosby B, et al. Liver transplantation for nonresectable liver metastases from colorectal cancer. Ann Surg. 2013;257(5):800\u20136.","journal-title":"Ann Surg"},{"issue":"3","key":"1482_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/bjs.10651","volume":"105","author":"H Grut","year":"2018","unstructured":"Grut H, Solberg S, Seierstad T, Revheim ME, Egge TS, Larsen SG, et al. Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases. Br J Surg. 2018;105(3):295\u2013301.","journal-title":"Br J Surg"},{"key":"1482_CR26","doi-asserted-by":"publisher","first-page":"182","DOI":"10.12659\/AOT.883893","volume":"18","author":"P Horvath","year":"2013","unstructured":"Horvath P, Konigsrainer I, Nadalin S, Beckert S, Loffler M, Konigsrainer A. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in a liver graft recipient: a case report. Ann Transplant. 2013;18:182\u20136.","journal-title":"Ann Transplant"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-018-1482-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12957-018-1482-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-018-1482-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T19:12:02Z","timestamp":1567624322000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-018-1482-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,5]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1482"],"URL":"https:\/\/doi.org\/10.1186\/s12957-018-1482-7","relation":{},"ISSN":["1477-7819"],"issn-type":[{"type":"electronic","value":"1477-7819"}],"subject":[],"published":{"date-parts":[[2018,9,5]]},"assertion":[{"value":"7 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study is approved by the Data Protection Official for Research for Oslo University Hospital, Oslo, Norway, if the consent form is signed. Reference number is not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient has given written informed consent to use her medical history including radiology in the manuscript. The informed consent form is provided and approved by the Data Protection Official for Research for Oslo University Hospital, Oslo, Norway.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"180"}}